Related Experiment Video

Updated: Jun 20, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Targeted therapies in the treatment of advanced non-small-cell lung cancer: update

L Mendoza1

  • 1INC Research, Prague, Czech Republic. Lmendoza@incresearch.com

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|September 8, 2009
PubMed

Insights

Targeted therapies show significant survival benefits for advanced non-small-cell lung cancer (NSCLC), offering new hope beyond chemotherapy. These agents, including EGFR and VEGFR inhibitors, are effective in first-line and recurrent disease settings.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Research

Background:

  • Chemotherapy has historically shown limited efficacy in advanced non-small-cell lung cancer (NSCLC) compared to best supportive care.
  • Recent advancements have introduced targeted therapies demonstrating meaningful clinical benefits in NSCLC treatment.

Purpose of the Study:

  • To review promising new targeted agents for non-small-cell lung cancer (NSCLC).
  • To highlight approved targeted therapies currently used in medical practice for tumor control and palliation.

Main Methods:

  • Review of clinical trial data for targeted therapies in advanced NSCLC.
  • Analysis of efficacy and survival advantage of new anti-cancer agents.

Main Results:

  • Selected targeted therapies, such as epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitors, have shown clinical efficacy.
  • Drugs like erlotinib (EGFR inhibitor) and bevacizumab (VEGFR inhibitor) demonstrate effectiveness in tumor control and palliation.
  • Survival advantages are observed in both first-line and recurrent NSCLC settings.

Conclusions:

  • Targeted therapies represent a significant advancement in the treatment of advanced NSCLC.
  • Approved agents offer improved outcomes for patients, including those with recurrent disease after chemotherapy failure.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...